Sels de 4-méthyl-n-[3-(4-méthyl-imidazol-1-yl)-5-trifluorométhyl-phényl]-3-(4-pyridine-3-yl-pyrimidine-2-ylamino)-benzamide
- 专利权人:
- Novartis AG;Novartis Pharma AG
- 发明人:
- 申请号：
- EP10150322.5
- 公开号：
- EP2186808B1
- 申请日:
- 2006.07.18
- 申请国别(地区):
- EP
- 年份:
- 2017
- 代理人:
- 摘要：
- Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide are prepared by various processes.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Monosodium monohydrate 4-methyl-N-[3-(4-methyl-imidazole-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridine-3-yl-pyrimidine-2-ylamine)-benzamide
- PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINES
- Process of preparing imatinib
- pyridines, pyrimidins, and pyrazines, as btk inhibitors, their uses and their manufacturing process, and pharmaceutical composition
- PROCESS FOR THE PREPARATION OF (R)-3-(6-(4-METHYLPHENYL)-PYRIDIN-3-YLOXY)-1-AZA-BICYCLO[2.2.2]OCTANE AND PROCESS FOR THE PREPARATION OF THE INTERMEDIATE 5-CHLORO-2-(4-METHYLPHENYL)PYRIDINE
